EZH2 and hepatocellular carcinoma: MiRNA is also common in hepatocellular carcinoma, an example is that Au SL et al.’s finding suggests that enhancer of zeste homolog 2 (EZH2) exerts its prometastatic function through epigenetic silencing of multiple tumor suppressor miRNAs including miR-101, miR-139-5p, let-7c, miR-125b, and miR-200b [18].